Hefei China Resources Norvatis Pharmaceutical

China Resources Novartis (Beijing) Pharmaceutical is a prominent joint venture between the China Resources Group and Novartis, focused on the manufacturing and distribution of high-quality pharmaceutical products in the Chinese market. The company operates a major production base that adheres to international GMP standards, specializing in cardiovascular, metabolic, and oncology treatments. By leveraging Novartis's global R&D capabilities and China Resources's extensive domestic distribution network, the entity provides essential medications such as Entresto and Diovan to millions of patients. The company plays a critical role in the localized production of innovative therapies, ensuring supply chain stability and accessibility within China's healthcare system.